Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 29
- Uncategorized
Cost vs Care: Can Clinics Stay Affordable While Scaling Responsibly?
Medical cannabis clinics are often driven to scale their operations quickly, out of a desire to reach more patients who could benefit from treatment and the need to remain affordable for them. But doing so shouldn’t come at the cost of regulatory compliance.
- Uncategorized
Countdown to Cannabis Europa London 2025: Celebrating Our Pioneering Sponsors
We are proud to be supported by some of the cannabis industry’s most forward-thinking and influential businesses. Their backing helps create an environment where innovation thrives, meaningful connections are made, and bold ideas can take shape.
- Uncategorized
US Spending Bill Takes Aim at Cannabis Rescheduling Project
As more details of the Trump administration’s fiscal plans for the year ahead come to light, so do more thinly veiled attacks on cannabis, this time the ongoing cannabis rescheduling process.
- Medical
Could Australia Be the Next Country to Impose Tariffs on Canadian Cannabis?
Australia’s medical cannabis market is thriving, with revenues expected to grow from around US$600m in 2024 to more than US$1.2bn by 2028, according to Prohibition Partners’ Global Cannabis Report: 5th Edition.
- Medical
US State Medical Cannabis Markets in ‘Dire Jeopardy’ as Critical Federal Protections Dropped by Trump
The Trump administration’s ‘One Big Beautiful Bill’, the federal government’s annual spending and tax omnibus legislation, has quietly dropped a key piece of legislation putting the country’s entire medical cannabis industry under threat.
- Events
Business of Cannabis Awards 2025: Full List of Nominees Revealed
The shortlist for the second annual Business of Cannabis Awards, Europe’s leading celebration of excellence across the cannabis sector, have been announced today.
- Hemp Industry
Federal ‘Back Door’ Intoxicating Hemp Killing Bill Makes Passes First Hurdle
A Republican-led US House committee has advanced a controversial spending bill that would redefine hemp under federal law, placing sweeping new restrictions on popular intoxicating hemp substances such as Delta-8 THC and many forms of CBD oils, a move that industry leaders say could devastate the $30 billion national hemp market.
- Uncategorized
EU Moves to Improve Conditions for Embattled Biotech Sector, Ananda’s Clinical Development Pushes On, & Celadon Remains on the Brink
In response to this growing exodus of promising biotech firms, the European Union has proposed a new Biotech Act, as part of ongoing efforts by the European Commission to strengthen the continent’s biotechnology and biomanufacturing sectors, which have struggled with fragmented rules and sluggish approval processes.
- Uncategorized
MediPharm On the Brink: Shareholder Revolt Reaches Boiling Point as Board Fight for Survival at Canandian Cannabis Giant
A bitter boardroom battle has erupted at MediPharm Labs, one of Canada’s leading pharmaceutical cannabis companies, as investor Apollo Capital moves to unseat the entire board amid allegations of financial misconduct, mismanagement, and self-enrichment.
- Companies
From Farm to Pharma: New Zealand’s Cannabis Powerhouses Are Coming to Europe
With Europe on their radar, a delegation of New Zealand companies is preparing to attend Cannabis Europa later this month. Business of Cannabis caught up with them ahead of the event to explore how they plan to connect with European counterparts, and where they see the most promising opportunities on the horizon.
- Uncategorized
‘It’s Disneyland for Cannabis’: Mary Jane Berlin Founder on Taking the Grassroots Festival to New Heights
Ahead of Mary Jane Berlin, which returns later this month as part of European Cannabis Week, CEO Duc Anh Dang, spoke to Business of Cannabis about taking the festival to the next level and learning lessons along the way.
- Adult-Use
Czech Republic Moves Closer to Cannabis Decriminalisation with Landmark Law
The Czech Republic’s Chamber of Deputies has approved a landmark amendment which, if passed through the Senate, will legalise home cultivation of up to three plants, home possession of up to 100g of cannabis per person, and public possession of up to 25g per person.
